![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| COVID-19 |
|
Free Subscription
2 Am J Respir Crit Care Med |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO COVID-19 is free of charge.
The Long-term Pneumonia Mortality Index. An International Multicenter Derivation
and Validation Study for Patients with Community-Acquired Pneumonia.
Am J Respir Crit Care Med. 2026 Feb 21:aamag060. doi: 10.1093.
PubMed
Abstract available
The first breaths after birth-early lung function in healthy term infants.
Am J Respir Crit Care Med. 2026 Jan 30:aamag008. doi: 10.1093.
PubMed
Abstract available
COVID-19 Vaccines for 2025-2026 in Adults Who Are Not Pregnant or
Immunocompromised: Rapid Practice Points From the American College of Physicians.
Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
PubMed
Abstract available
Annals Video Summary - COVID-19 Vaccines in Adults Who Are Not Pregnant or
Immunocompromised.
Ann Intern Med. 2026 Feb 24:e2600306VS. doi: 10.7326/ANNALS-26-00306.
PubMed
Summary for Patients: COVID-19 Vaccines for 2025-2026.
Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
PubMed
Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in
Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American
College of Physicians.
Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05044.
PubMed
Abstract available
Onvansertib and vilazodone inhibit SARS-CoV-2 replication via suppression of
METTL3 RNA-m(6)A enzymatic activity.
Antiviral Res. 2026 Feb 19:106376. doi: 10.1016/j.antiviral.2026.106376.
PubMed
Abstract available
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal
COVID-19 infections in immunocompromised patients.
Clin Infect Dis. 2026 Feb 25:ciag115. doi: 10.1093.
PubMed
Abstract available
Corrigendum to "Nasal microbiota and clinical features in acute flu-like illness:
COVID-19 status and long COVID follow-up" [International Journal of Infectious
Diseases 162 (2026) 108196 https://doi.org/10.1016/j.ijid.2025.108196].
Int J Infect Dis. 2026;165:108441.
PubMed
Epidemiology of virologically confirmed RSV, influenza and COVID-19 in adults in
England, 2023-2024: Primary Care Observational Study of Acute Respiratory
Infection (ObservatARI).
J Infect. 2026 Feb 21:106714. doi: 10.1016/j.jinf.2026.106714.
PubMed
Abstract available
SARS-CoV-2 Main Protease Activates ERK1/2 Signaling to Facilitate
MEG2-STAT3-Mediated Suppression of ACE2.
J Med Virol. 2026;98:e70855.
PubMed
Abstract available
EXPRESSION OF CONCERN: The Emergence, Spread and Vanishing of a French SARS-CoV-2
Variant Exemplifies the Fate of RNA Virus Epidemics and Obeys the Mistigri Rule.
J Med Virol. 2026;98:e70842.
PubMed
The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity
in the naturally susceptible feline model of infection.
J Virol. 2026 Feb 27:e0064425. doi: 10.1128/jvi.00644.
PubMed
Abstract available
COVID's origins: what we do and don't know.
Nature. 2026;650:829-833.
PubMed
Thank you for your interest in scientific medicine.